JP2015531378A5 - - Google Patents

Download PDF

Info

Publication number
JP2015531378A5
JP2015531378A5 JP2015534749A JP2015534749A JP2015531378A5 JP 2015531378 A5 JP2015531378 A5 JP 2015531378A5 JP 2015534749 A JP2015534749 A JP 2015534749A JP 2015534749 A JP2015534749 A JP 2015534749A JP 2015531378 A5 JP2015531378 A5 JP 2015531378A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
amino
lactam compound
arginine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015534749A
Other languages
English (en)
Japanese (ja)
Other versions
JP6186001B2 (ja
JP2015531378A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/062256 external-priority patent/WO2014052799A1/en
Publication of JP2015531378A publication Critical patent/JP2015531378A/ja
Publication of JP2015531378A5 publication Critical patent/JP2015531378A5/ja
Application granted granted Critical
Publication of JP6186001B2 publication Critical patent/JP6186001B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015534749A 2012-09-27 2013-09-27 タゾバクタムアルギニン抗菌性組成物 Active JP6186001B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261706399P 2012-09-27 2012-09-27
US61/706,399 2012-09-27
PCT/US2013/062256 WO2014052799A1 (en) 2012-09-27 2013-09-27 Tazobactam arginine antibiotic compositions

Publications (3)

Publication Number Publication Date
JP2015531378A JP2015531378A (ja) 2015-11-02
JP2015531378A5 true JP2015531378A5 (enExample) 2016-11-17
JP6186001B2 JP6186001B2 (ja) 2017-08-23

Family

ID=50389002

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015534749A Active JP6186001B2 (ja) 2012-09-27 2013-09-27 タゾバクタムアルギニン抗菌性組成物

Country Status (12)

Country Link
US (4) US20150306076A1 (enExample)
EP (1) EP2900244B1 (enExample)
JP (1) JP6186001B2 (enExample)
KR (1) KR102143256B1 (enExample)
CN (1) CN105025901B (enExample)
AU (2) AU2013323280A1 (enExample)
BR (1) BR112015006868B1 (enExample)
CA (1) CA2886402A1 (enExample)
IN (1) IN2015DN03113A (enExample)
MX (1) MX2015004039A (enExample)
RU (1) RU2671485C2 (enExample)
WO (1) WO2014052799A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
US20140274994A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Stabilizing ceftolozane
AU2014233637A1 (en) 2013-09-09 2015-03-26 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) * 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
KR101638311B1 (ko) * 2016-02-29 2016-07-12 (주)에프원테크놀로지 3축 코일 안테나의 단자부 및 이의 제조방법
CN107847502A (zh) * 2016-03-31 2018-03-27 沃克哈特有限公司 抗菌组合物
US11542279B2 (en) * 2016-06-06 2023-01-03 Merck Sharp & Dohme Llc Solid forms of ceftolozane and processes for preparing
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
DK3833665T3 (da) 2018-08-09 2023-10-09 Antabio Sas Diazabicyclooctanoner som hæmmere af serin-beta-lactamaser

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8323034D0 (en) * 1983-08-26 1983-09-28 Fujisawo Pharmaceutical Co Ltd 7-substituted-3-vinyl-3-cephem compounds
JP2648750B2 (ja) * 1988-03-02 1997-09-03 大塚化学株式会社 β−ラクタム誘導体の製造方法
JP3233407B2 (ja) * 1993-11-06 2001-11-26 大鵬薬品工業株式会社 結晶性ペニシリン誘導体並びにその製造及び使用
CN1109688C (zh) * 1999-01-12 2003-05-28 中国药品生物制品检定所 他唑巴坦半水合物的制备与应用
JP3743823B2 (ja) 2000-08-11 2006-02-08 大塚化学ホールディングス株式会社 ペニシリン結晶及びその製造法
JP3306473B1 (ja) 2001-05-01 2002-07-24 大塚化学株式会社 β−ラクタム化合物の無水結晶及びその製造法
JP2002338578A (ja) * 2001-05-14 2002-11-27 Otsuka Chem Co Ltd β−ラクタム化合物の水和物結晶
DK1556389T6 (da) 2002-10-30 2015-05-11 Astellas Pharma Inc Cephemforbindelser
DE602005022939D1 (de) * 2004-12-02 2010-09-23 Venus Remedies Ltd Zusammensetzungen zur bekämpfung von beta-lactamase-vermittelter antibiotischer resistenz mittels beta-lactamase-hemmern für injektionen
BRPI0616642A2 (pt) * 2005-09-29 2011-06-28 Nektar Therapeutics formulações de antibióticos, doses unitárias, kits e métodos
JP5852316B2 (ja) * 2010-03-30 2016-02-03 富山化学工業株式会社 ピペラシリン含有懸濁液の製造法
US8476425B1 (en) * 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140274991A1 (en) * 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
US8906898B1 (en) * 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Similar Documents

Publication Publication Date Title
JP2015531378A5 (enExample)
RU2671485C2 (ru) Антибиотические композиции тазобактама аргинина
US8883773B2 (en) Cephem compound having pseudo-catechol group
DK2917223T3 (en) 2 SUBSTITUTED CEPHEM CONNECTIONS
JP5852562B2 (ja) 新規なセフェム誘導体
US8476425B1 (en) Tazobactam arginine compositions
RU2014117658A (ru) Антибактериальные соединения
WO2010118361A1 (en) Beta lactamase inhibitors
JPH01110690A (ja) 水溶性抗生物質組成物および新規セフェム化合物の水溶性塩類
US9242999B2 (en) Cephem compound having pyridinium group
WO2020184399A1 (ja) 抗菌用医薬組成物
WO2021049600A1 (ja) 抗菌作用を有する医薬組成物
CN109503629B (zh) 一种头孢唑肟酸的合成方法
US20150344502A1 (en) Cephem compound
WO2016028670A1 (en) Salt forms of ceftolozane
Zhang et al. Design, synthesis and biological evaluation of sulfenimine cephalosporin analogues as β-lactamase inhibitors
JPH10182655A (ja) 新規セフェム化合物
JPH04338392A (ja) 新規セフェム誘導体及びその製造方法